A familial form of conduction defect related to a mutation in the PRKAG2 gene

Europace

Volumn 9, Issue 8, 2007, Pages 597-600

  Charron, Philippe ^a   Genest, Marc ^b   Richard, Pascale ^c   Komajda, Michel ^a   Pochmalicki, Gilbert ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b Centre Hospitalier Léon Binet   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

AMP activated protein kinase; Conduction defect; Preexcitation; PRKAG2 gene

Indexed keywords

CAPTOPRIL; CELL DNA; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIZZINESS; DNA EXTRACTION; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HUMAN CELL; HYPERTENSION; LYMPHOCYTE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PR INTERVAL; PRIORITY JOURNAL; SINUS NODE DYSFUNCTION; WOLFF PARKINSON WHITE SYNDROME;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MULTIENZYME COMPLEXES; MUTATION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES;

EID: 34547952651     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum071     Document Type: Article

References (9)

1. Roberts R. Genomics and cardiac arrhythmias. J Am Coll Cardiol 2006;47:9-21.
2. Sarkozy A, Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol. 2005;16(Suppl. 1):S8-20.
3. Oliveira SM, Ehtisham J, Redwood CS, Ostman-Smith I, Blair EM, Watkins H. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: Implications for kinase function and disease pathogenesis. J Mol Cell Cardiol. 2003;35:1251-5.
4. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS et al. Identification of a gene responsible for familial Wolf Parkinson White Syndrome. N Engl J Med 2001;344:1823-31.
5. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B et al. Mutations in the gamma 2 subunit of AMP- activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10:1215-20.
6. Arad M, Benson DW, Perez-Atayade AR, McKenna WJ, Sparks EA, Kanter RJ et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109:357-62.
7. Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E et al. Adenosine morophosphate activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolf-Parkinson-White syndrome. J Am Coll Cardiol 2005;45:922-30.
8. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 2003;107:2850-6.
9. Sichu JS, Rajawat YS, Rami TG, Gollob MH, Wang Z, Yuan R et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 2005;111:21-9.